{"product_id":"enroflox-inj-50-mg-ml-100-ml-enrofloxacin-cattle-calves-sheep-goats-pigs-and-dogs","title":"ENROFLOX INJ. 50 mg\/ml 100 ML \/\/ Enrofloxacin \/\/  cattle (calves), sheep, goats, pigs and dogs","description":"\u003cdiv id=\"w-node-_30228ee4-8179-184e-67ac-5b2b6cbfa47f-daab23cd\" class=\"w-layout-cell cell-3\"\u003e\n\u003cdiv class=\"div-block-21\"\u003e\n\u003ch4 class=\"heading-2\"\u003e\u003cstrong\u003e\u003cspan\u003eDirections\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cdiv class=\"product-rich-text w-richtext\"\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCalves\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of respiratory tract infections caused by enrofloxacin susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePasteurella multocida, Mannheimia haemolytica\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e and \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMycoplasma\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of digestive tract infections caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of septicaemia caused by enrofloxacin susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of arthritis associated with acute mycoplasmosis caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMycoplasma bovis.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOvine\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of digestive tract infections caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of septicaemia caused by enrofloxacin susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of mastitis caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eStaphylococcus aureus\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e and \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGoats\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of respiratory tract infections caused by enrofloxacin susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePasteurella multocida, Mannheimia haemolytica\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e and \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMycoplasma\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of digestive tract infections caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of septicaemia caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of mastitis caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eStaphylococcus aureus\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e and \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePorcine\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of respiratory tract infections caused by enrofloxacin susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePasteurella multocida, Mycoplasma\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp. and \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eActinobacillus pleuropneumoniae.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e Treatment of digestive tract infections caused by enrofloxacin susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of septicaemia caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003edog\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment of infections of the digestive, respiratory and urogenital tracts (including prostatitis, adjuvant antibiotic therapy for pyometra), skin and wound infections, otitis (external\/media), caused by enrofloxacin-susceptible strains of: \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eStaphylococcus\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e., Escherichia coli, Pasteurella\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e., Klebsiella\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e., Bordetella\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp. \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e, Pseudomonas\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e and \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eProteus\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"w-node-_1606beab-c0b8-e1ac-8388-3485aaed7514-daab23cd\" class=\"w-layout-cell\"\u003e\n\u003cdiv class=\"med-image\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"w-node-_6906d709-f081-b9d1-09fb-31ac0e8a98db-daab23cd\" class=\"w-layout-cell\"\u003e\n\u003cdiv class=\"product-rich-text w-richtext\"\u003e\n\u003ch4\u003e\n\u003cspan\u003e\u003cstrong\u003eCOMPOSITION\u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/strong\u003e\n\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003e\u003cspan\u003eActive substance:\u003c\/span\u003e\u003c\/em\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEnrofloxacin ..... 50 mg\/ml\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003e\u003cspan\u003eExcipients:\u003c\/span\u003e\u003c\/em\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAlcool n-butilic ..... 30 mg\/ml\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eCONTRAINDICATIONS\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eDo not use the product in case of known resistance to quinolones. Do not use the product in case of disturbances in cartilage development and\/or during injuries of the musculoskeletal system, especially in joints that are normally stressed or in joints that are stressed by body weight.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not use the product on dogs less than 1 year old or on breeding males less than 18 months old.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not use in case of hypersensitivity to the active substance or to any of the excipients.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt should not be used in growing horses as it may cause possible articular cartilage damage.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eADVERSE REACTIONS\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eLocal tissue reactions may occasionally occur at the injection site. During the period of rapid growth, enrofloxacin may affect the development of articular cartilage.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e‍\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eDOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eIntravenous, subcutaneous or intramuscular administration. Repeated injections should be performed at different injection sites.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCalves\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e5 mg enrofloxacin\/kg body weight, which corresponds to 1 ml product\/10 kg body weight, once a day, for 3-5 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eArthritis associated with acute mycoplasmosis caused by enrofloxacin-susceptible strains of \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMycoplasma bovis\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e : 5 mg enrofloxacin\/kg body weight, corresponding to 1 ml product\/10 kg body weight, once daily for 5 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe product can be administered by slow intravenous injection or subcutaneously. No more than 10 ml should be administered at a single subcutaneous injection site.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSheep and goats\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e5 mg enrofloxacin\/kg body weight, corresponding to 1 ml product\/10 kg body weight, once daily by subcutaneous injection, for 3 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNo more than 6 ml should be administered at a single subcutaneous injection site.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePorcine\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e2.5 mg enrofloxacin\/kg body weight, corresponding to 0.5 ml product\/10 kg body weight, once daily by intramuscular injection, for 3 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDigestive tract infections or septicaemia caused by \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e : 5 mg enrofloxacin\/kg body weight, corresponding to 1 ml product\/10 kg body weight, once daily by intramuscular injection for 3 days. No more than 3 ml should be administered at a single intramuscular injection site.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003edog\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e5 mg enrofloxacin\/kg body weight, corresponding to 1 ml product\/10 kg body weight, once daily, by subcutaneous injection, for up to 5 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTreatment can be initiated with the injectable product and maintained with enrofloxacin tablets. The duration of treatment should be based on the approved duration of treatment for the appropriate indication, as per the product information for the tablets. If clinical improvement is not observed within the first 2-3 days, additional measures should be taken, such as repeating antibiograms or changing antimicrobial therapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eRECOMMENDATIONS ON CORRECT ADMINISTRATION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eThe dose applied at a single injection site will not exceed 10 ml in calves, 5 ml in sheep and goats and 2.5 ml in lambs and kids.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEnrofloxacin is administered at the usual administration sites, for example in pigs in the muscles behind the ear.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not exceed the recommended dose. To ensure a correct dose, body weight should be determined as accurately as possible to avoid underdosing.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eWAITING TIMES\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCalves\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAfter intravenous injection\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMeat and offal: 5 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAfter subcutaneous injection\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMeat and offal: 12 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNot authorised for use in animals producing milk for human consumption.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSheep\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (meat and offal): 4 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMilk: 3 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGoats\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (meat and offal): 6 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eMilk: 4 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePigs\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (meat and offal): 13 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e‍\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eSPECIAL STORAGE PRECAUTIONS\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eKeep out of sight and reach of children.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not store above 25ºC. Do not refrigerate or freeze.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStore in the original packaging. Store in a dry place. Protect from direct light.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not use after the expiry date stated on the label.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eVALIDITY PERIOD\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eShelf life of the veterinary medicinal product as packaged for sale: 2 years.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eShelf life after first opening the immediate packaging: 28 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eSPECIAL WARNINGS\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSpecial precautions for use in animals\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eOfficial and local regulations on antimicrobials should be taken into account when the product is used. Fluoroquinolones should be reserved for treatment that is clinically inadequate or will be inadequately effective with other classes of antimicrobials. Fluoroquinolones should be used only on the basis of susceptibility testing, whenever possible. Use of the product deviating from the instructions in the SPC may lead to increased bacterial resistance to fluoroquinolones and may lead to decreased efficacy of treatment with other quinolones due to possible cross-resistance. Degenerative changes in articular cartilage have been observed in calves treated orally with 30 mg enrofloxacin\/kg body weight for 14 days. The use of enrofloxacin in growing lambs at the recommended dose for 15 days caused histological changes in articular cartilage that were not associated with clinical signs.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSpecial precautions to be taken by the person administering the veterinary medicinal product to animals\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis product is an alkaline solution. In case of accidental contact with skin or eyes, rinse thoroughly with water, seek medical advice immediately and show the package leaflet or the label to the physician. Do not eat, drink or smoke when handling the product. Prevent self-injection accidents. If these occur, seek medical advice immediately. Avoid direct contact with skin due to sensitivity, contact dermatitis and possible allergic reactions. Wear protective gloves. People with known hypersensitivity to (fluoro)quinolones should avoid contact with this product.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUse during pregnancy or lactation\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEnrofloxacin can be used during pregnancy and lactation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInteractions with other medicinal products or other forms of interaction\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCaution is advised when using flunixin and enrofloxacin concomitantly in dogs to avoid adverse reactions. The decrease in clearance of these substances following concomitant administration of flunixin and enrofloxacin indicates that these substances interact during the elimination phase. Thus, in dogs, concomitant administration of enrofloxacin and flunixin increased the AUC and plasma half-life of flunixin, and also increased the half-life and reduced the C \u003c\/span\u003e\u003csub\u003e\u003cspan\u003emax\u003c\/span\u003e\u003c\/sub\u003e\u003cspan\u003e of enrofloxacin. Do not combine with other antibiotics such as tetracyclines, macrolides or chloramphenicol as they may produce antagonistic effects.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eOverdose (symptoms, emergency procedures, antidotes), as appropriate\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not exceed the recommended dose. In accidental overdose there is no antidote and therapy is symptomatic.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eincompatibility\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e‍\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eSPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eMedicines should not be thrown away via wastewater or household waste. Ask your veterinarian or pharmacist for information on how to dispose of medicines no longer required. These measures help to protect the environment. Treated animals should be kept in shelters throughout the treatment period and their droppings should be collected and NOT used for soil fertilization.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cdiv id=\"w-node-_30228ee4-8179-184e-67ac-5b2b6cbfa47f-daab23cd\" class=\"w-layout-cell cell-3\"\u003e\n\u003cdiv class=\"div-block-21\"\u003e\n\u003ch4 class=\"heading-2\"\u003e\u003cstrong\u003e\u003cspan\u003eIndicazioni\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cdiv class=\"product-rich-text w-richtext\"\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eVitelli\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento delle infezioni delle vie respiratorie causate da ceppi sensibili all'enrofloxacina di \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePasteurella multocida, Mannheimia haemolytica\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e e \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMycoplasma\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento delle infezioni del tratto digerente causate da ceppi di Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento della setticemia causata da ceppi di Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento dell'artrite associata a micoplasmosi acuta causata da ceppi di \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMycoplasma bovis sensibili all'enrofloxacina.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eOvino\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento delle infezioni del tratto digerente causate da ceppi di Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento della setticemia causata da ceppi di Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003c\/span\u003e\u003cem\u003e\u003cspan\u003eTrattamento della mastite causata da ceppi di Staphylococcus aureus\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e ed Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCapre\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento delle infezioni delle vie respiratorie causate da ceppi sensibili all'enrofloxacina di \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePasteurella multocida, Mannheimia haemolytica\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e e \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMycoplasma\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento delle infezioni del tratto digerente causate da ceppi di Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento della setticemia causata da ceppi di Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003c\/span\u003e\u003cem\u003e\u003cspan\u003eTrattamento della mastite causata da ceppi di Staphylococcus aureus\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e ed Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSuino\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento delle infezioni delle vie respiratorie causate da ceppi sensibili all'enrofloxacina di \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePasteurella multocida, Mycoplasma\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp. e \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eActinobacillus pleuropneumoniae.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e Trattamento delle infezioni del tratto digerente causate da ceppi di Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento della setticemia causata da ceppi di Escherichia coli sensibili all'enrofloxacina \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ecane\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTrattamento delle infezioni del tratto digerente, respiratorio e urogenitale (inclusa la prostatite, terapia antibiotica adiuvante per la piometra), infezioni della pelle e delle ferite, otite (esterna\/media), causate da ceppi sensibili all'enrofloxacina di: \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eStaphylococcus\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e., Escherichia coli, Pasteurella\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e., Klebsiella\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e., Bordetella\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp. Specie di \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePseudomonas \u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e\u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e e \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eProteus\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e spp \u003c\/span\u003e\u003cem\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"w-node-_1606beab-c0b8-e1ac-8388-3485aaed7514-daab23cd\" class=\"w-layout-cell\"\u003e\n\u003cdiv class=\"med-image\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"w-node-_6906d709-f081-b9d1-09fb-31ac0e8a98db-daab23cd\" class=\"w-layout-cell\"\u003e\n\u003cdiv class=\"product-rich-text w-richtext\"\u003e\n\u003ch4\u003e\n\u003cspan\u003e\u003cstrong\u003eCOMPOSIZIONE\u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/strong\u003e\n\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003e\u003cspan\u003eSostanza attiva:\u003c\/span\u003e\u003c\/em\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEnrofloxacina ..... 50 mg\/ml\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003e\u003cspan\u003eEccipienti:\u003c\/span\u003e\u003c\/em\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAlcool n-butilico ..... 30 mg\/ml\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eCONTROINDICAZIONI\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eNon utilizzare il prodotto in caso di nota resistenza ai chinoloni. Non utilizzare il prodotto in caso di disturbi nello sviluppo della cartilagine e\/o in caso di lesioni all'apparato muscolo-scheletrico, in particolare in articolazioni normalmente sottoposte a stress o sollecitate dal peso corporeo.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon utilizzare il prodotto su cani di età inferiore a 1 anno e su maschi riproduttori di età inferiore a 18 mesi.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon usare in caso di ipersensibilità al principio attivo o ad uno qualsiasi degli eccipienti.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon deve essere utilizzato nei cavalli in crescita poiché potrebbe causare danni alla cartilagine articolare.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eREAZIONI AVVERSE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eOccasionalmente possono verificarsi reazioni tissutali locali nel sito di iniezione. Durante il periodo di crescita rapida, l'enrofloxacina può influenzare lo sviluppo della cartilagine articolare.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eDOSAGGIO PER CIASCUNA SPECIE, VIA E MODO DI SOMMINISTRAZIONE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eSomministrazione endovenosa, sottocutanea o intramuscolare. Le iniezioni ripetute devono essere eseguite in siti di iniezione diversi.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eVitelli\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e5 mg di enrofloxacina\/kg di peso corporeo, corrispondenti a 1 ml di prodotto\/10 kg di peso corporeo, una volta al giorno, per 3-5 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eArtrite associata a micoplasmosi acuta causata da ceppi di \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eMycoplasma bovis\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e sensibili all'enrofloxacina : 5 mg di enrofloxacina\/kg di peso corporeo, corrispondenti a 1 ml di prodotto\/10 kg di peso corporeo, una volta al giorno per 5 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIl prodotto può essere somministrato tramite iniezione endovenosa lenta o per via sottocutanea. Non somministrare più di 10 ml in un singolo sito di iniezione sottocutanea.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePecore e capre\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e5 mg di enrofloxacina\/kg di peso corporeo, corrispondenti a 1 ml di prodotto\/10 kg di peso corporeo, una volta al giorno tramite iniezione sottocutanea, per 3 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon somministrare più di 6 ml in un singolo sito di iniezione sottocutanea.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSuino\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e2,5 mg di enrofloxacina\/kg di peso corporeo, corrispondenti a 0,5 ml di prodotto\/10 kg di peso corporeo, una volta al giorno tramite iniezione intramuscolare, per 3 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInfezioni del tratto digerente o setticemia causate da \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eEscherichia coli\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e : 5 mg di enrofloxacina\/kg di peso corporeo, corrispondenti a 1 ml di prodotto\/10 kg di peso corporeo, una volta al giorno tramite iniezione intramuscolare, per 3 giorni. Non somministrare più di 3 ml in un singolo sito di iniezione intramuscolare.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ecane\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e5 mg di enrofloxacina\/kg di peso corporeo, corrispondenti a 1 ml di prodotto\/10 kg di peso corporeo, una volta al giorno, tramite iniezione sottocutanea, per un massimo di 5 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIl trattamento può essere iniziato con un prodotto iniettabile e continuato con compresse di enrofloxacina. La durata del trattamento deve basarsi sulla durata del trattamento approvata per l'indicazione appropriata, come riportato nelle informazioni sul prodotto delle compresse. Se non si osservano miglioramenti clinici nei primi 2-3 giorni, è necessario adottare misure aggiuntive, come la ripetizione degli antibiogrammi o la modifica della terapia antimicrobica.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eRACCOMANDAZIONI PER UNA CORRETTA SOMMINISTRAZIONE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eLa dose applicata in un singolo sito di iniezione non supererà i 10 ml nei vitelli, i 5 ml negli ovini e nei caprini e i 2,5 ml negli agnelli e nei capretti.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eL'enrofloxacina viene somministrata nei consueti siti di somministrazione, ad esempio nei suini nei muscoli dietro l'orecchio.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon superare la dose consigliata. Per garantire un dosaggio corretto, il peso corporeo deve essere determinato nel modo più accurato possibile per evitare un sottodosaggio.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eTEMPI DI ATTESA\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eVitelli\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDopo l'iniezione endovenosa\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCarne e frattaglie: 5 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDopo l'iniezione sottocutanea\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCarne e interiora: 12 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon autorizzato per l'uso su animali che producono latte destinato al consumo umano.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eOvini\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (carne e frattaglie): 4 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLatte: 3 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCapre\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (carne e frattaglie): 6 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLatte: 4 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSuini\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (carne e frattaglie): 13 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003ePRECAUZIONI SPECIALI PER LA CONSERVAZIONE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eTenere fuori dalla vista e dalla portata dei bambini.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon conservare a temperatura superiore ai 25ºC. Non refrigerare o congelare.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eConservare nella confezione originale. Conservare in luogo asciutto. Proteggere dalla luce diretta.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon utilizzare dopo la data di scadenza riportata sull'etichetta.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003ePERIODO DI VALIDITÀ\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003ePeriodo di validità del medicinale veterinario confezionato per la vendita: 2 anni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePeriodo di validità dopo la prima apertura del confezionamento primario: 28 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eAVVERTENZE SPECIALI\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePrecauzioni speciali per l'impiego negli animali\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDurante l'uso del prodotto è necessario tenere conto delle normative ufficiali e locali relative alle sostanze antimicrobiche. I fluorochinoloni saranno tenuti come riserva per i trattamenti che rispondono male o che risponderanno male ad altre classi di sostanze antimicrobiche in ambito clinico. Se possibile, i fluorochinoloni dovrebbero essere utilizzati solo sulla base di test di sensibilità. L'uso del prodotto in modo non conforme alle istruzioni riportate nel riassunto delle caratteristiche del prodotto può portare a un aumento della resistenza batterica ai fluorochinoloni e può indurre una riduzione dell'efficacia del trattamento con altri chinoloni, a causa di una possibile resistenza crociata. Sono state osservate alterazioni degenerative della cartilagine articolare nei vitelli trattati per via orale con 30 mg di enrofloxacina\/kg di peso corporeo per 14 giorni. L'uso di enrofloxacina negli agnelli in crescita, alla dose raccomandata, per 15 giorni ha causato alterazioni istologiche nella cartilagine articolare non associate a segni clinici.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePrecauzioni speciali che devono essere adottate dalla persona che somministra il medicinale veterinario agli animali\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eQuesto prodotto è una soluzione alcalina. In caso di contatto accidentale con la pelle o gli occhi, sciacquare abbondantemente con acqua, consultare immediatamente un medico e mostrargli il foglietto illustrativo o l'etichetta del prodotto. Non mangiare, bere o fumare durante la manipolazione del prodotto. Prevenire gli incidenti dovuti all'autoiniezione. Se si verificano questi sintomi, consultare immediatamente un medico. Evitare il contatto diretto con la pelle a causa di sensibilità, dermatite da contatto e possibili reazioni allergiche. Indossare guanti protettivi. Le persone con nota ipersensibilità ai (fluoro)chinoloni devono evitare il contatto con questo prodotto.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUtilizzare durante la gravidanza o l'allattamento\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eL'enrofloxacina può essere utilizzata durante la gravidanza e l'allattamento.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInterazioni con altri medicinali o altre forme di interazione\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSi raccomanda cautela durante l'uso concomitante di flunixina ed enrofloxacina nei cani per evitare reazioni avverse. La diminuzione della clearance di queste sostanze a seguito della somministrazione concomitante di flunixina ed enrofloxacina indica che queste sostanze interagiscono durante la fase di eliminazione. Pertanto, nei cani, la somministrazione concomitante di enrofloxacina e flunixina ha aumentato l'AUC e l'emivita plasmatica della flunixina, oltre ad aver aumentato l'emivita e ridotto la C \u003c\/span\u003e\u003csub\u003e\u003cspan\u003emax\u003c\/span\u003e\u003c\/sub\u003e\u003cspan\u003e dell'enrofloxacina. Non combinare con altri antibiotici come tetracicline, macrolidi o cloramfenicolo poiché potrebbero produrre un effetto antagonista.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSovradosaggio (sintomi, procedure di emergenza, antidoti), a seconda dei casi\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon superare la dose consigliata. In caso di sovradosaggio accidentale non esiste antidoto e la terapia è sintomatica.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eincompatibilità\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn assenza di studi di compatibilità, questo medicinale veterinario non deve essere miscelato con altri medicinali veterinari.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003ePRECAUZIONI SPECIALI PER LO SMALTIMENTO DEL PRODOTTO NON UTILIZZATO O DEI RIFIUTI, SE PRESENTI\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eI medicinali non devono essere gettati nelle acque reflue o nei rifiuti domestici. Chiedi al tuo veterinario o al farmacista informazioni su come smaltire i medicinali che non utilizzi più. Queste misure contribuiscono alla tutela dell’ambiente. Gli animali trattati saranno tenuti in rifugi per tutta la durata del trattamento e i loro escrementi saranno raccolti e NON saranno utilizzati per la fertilizzazione del terreno.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Crida Pharm","offers":[{"title":"Default Title","offer_id":50044324118875,"sku":"","price":29.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0476\/3261\/3543\/files\/863834_product.jpg?v=1739201820","url":"https:\/\/www.petshopluna.com\/en-gb\/products\/enroflox-inj-50-mg-ml-100-ml-enrofloxacin-cattle-calves-sheep-goats-pigs-and-dogs","provider":"Pet Shop Maya","version":"1.0","type":"link"}